Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by StockNew

StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently weighed in on ONCT. Oppenheimer downgraded Oncternal Therapeutics from an outperform rating to a market perform rating […]

Related Keywords

San Diego , California , United States , Davidf Hale , Jamesb Breitmeyer , , Ci Private Wealth , Securities Exchange Commission , Richmond Brothers Inc , Cantor Fitzgerald , Oncternal Therapeutics Inc , Waypoint Capital Advisors , Maxim Group , Millennium Management , Susquehanna International Group , Oncternal Therapeutics , Get Rating , Capital Acquisition , Capital Management , Therapeutics Trading Down , Exchange Commission , International Group , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,